Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU.
František DuškaPetr WaldaufMilada HalačováVáclav ZvoníčekJakub BalaMartin BalíkJan BenešOlga KlementováIrena KozákováViktor KubrichtAnne Le RoyTomáš VymazalVeronika ŘehořováVladimír Černýnull nullPublished in: Trials (2020)
Clinical trials.gov: NCT04339816 (Registered on 9 April 2020, amended on 22 June 2020); Eudra CT number: 2020-001456-18 (Registered on 29 March 2020).
Keyphrases
- coronavirus disease
- clinical trial
- study protocol
- intensive care unit
- randomized controlled trial
- respiratory syndrome coronavirus
- image quality
- computed tomography
- dual energy
- contrast enhanced
- mechanical ventilation
- sars cov
- positron emission tomography
- phase ii
- sewage sludge
- magnetic resonance
- open label
- double blind